IGM Biosciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.55 | $291.95 M | -3.13 | 54 | $0 |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $12.52 | $1.29 B | -7.16 | 85 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.61 | $217.51 M | -3.7 | 54 | $0 |
 ERAS
|
Erasca, Inc. | $2.69 | $647.94 M | -2.83 | 126 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.49 | $243.38 M | -1.59 | 133 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $1.90 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 14 | $9.16 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.49 | $652.38 M | -6.03 | 28 | $0 |
 PASG
|
Passage Bio, Inc. | $0.51 | $73.04 M | -0.77 | 58 | $0 |
 RNA
|
Avidity Biosciences, Inc. | $43.25 | $2.54 B | -8.99 | 253 | $9.56 M |
 RVMD
|
Revolution Medicines, Inc. | $56.71 | $6.66 B | -10.51 | 490 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.44 | $774.50 M | -6.14 | 110 | $8.78 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |